Genocea's Positive Cancer Data Leads To A Potential Catalyst Opportunity In 2020 [Seeking Alpha]
Genocea Biosciences, Inc. (GNCA)
Last genocea biosciences, inc. earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.genocea.com
Company Research
Source: Seeking Alpha
Genocea's Positive Cancer Data Leads To A Potential Catalyst Opportunity In 2020 Summary Genocea recently reported strong immunogenicity data from its phase 1/2a study using its neoantigen vaccine GEN-009 to treat patients with multiple types of cancer. Patients treated with GEN-009 achieved a 91% T cell response which bodes well for additional efficacy data expected from the same phase 1/2a study in 2020. Genocea intends to use its ATLAS platform in partnership with Iovance and its use of TILs; ATLAS for solid target selection and TILs to avoid tumor suppression. Genocea Biosciences has $29 million in cash as of March 31, 2019, which is expected to last into Q1 of 2020; cash raise might be needed by Q4 of 2019. Genocea Biosciences ( GNCA presented some outstanding immunogenicity data Immunogenicity Data Sets Up Catalyst In 2020 The phase 1/2a clinical trial is known as GEN-009-101 and is using GEN-009 to treat patients with multiple types of cancer. These include: non-small cell lung
Show less
Read more
Impact Snapshot
Event Time:
GNCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GNCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GNCA alerts
High impacting Genocea Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics